331 related articles for article (PubMed ID: 21162654)
1. Advances in proteomic techniques for biomarker discovery in COPD.
Casado B; Luisetti M; Iadarola P
Expert Rev Clin Immunol; 2011 Jan; 7(1):111-23. PubMed ID: 21162654
[TBL] [Abstract][Full Text] [Related]
2. Proteomics-based diagnosis of chronic obstructive pulmonary disease: the hunt for new markers.
Casado B; Iadarola P; Luisetti M; Kussmann M
Expert Rev Proteomics; 2008 Oct; 5(5):693-704. PubMed ID: 18937559
[TBL] [Abstract][Full Text] [Related]
3. Lipid metabolite levels of prostaglandin D2 and eicosapentaenoic acid recovered from bronchoalveolar lavage fluid correlate with lung function of chronic obstructive pulmonary disease patients and controls.
Csanky E; Rühl R; Scholtz B; Vasko A; Takacs L; Hempel WM
Electrophoresis; 2009 Apr; 30(7):1228-34. PubMed ID: 19294692
[TBL] [Abstract][Full Text] [Related]
4. Proteomics-based biomarkers in chronic obstructive pulmonary disease.
Chen H; Wang D; Bai C; Wang X
J Proteome Res; 2010 Jun; 9(6):2798-808. PubMed ID: 20387909
[TBL] [Abstract][Full Text] [Related]
5. Biomarker discovery for kidney diseases by mass spectrometry.
Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
[TBL] [Abstract][Full Text] [Related]
6. Role of proteomics in the investigation of pulmonary fibrosis.
Govender P; Baugh JA; Pennington SR; Dunn MJ; Donnelly SC
Expert Rev Proteomics; 2007 Jun; 4(3):379-88. PubMed ID: 17552922
[TBL] [Abstract][Full Text] [Related]
7. Breath condensate nitrite correlates with hyperinflation in chronic obstructive pulmonary disease.
Gessner C; Hammerschmidt S; Kuhn H; Hoheisel G; Gillissen A; Sack U; Wirtz H
Respir Med; 2007 Nov; 101(11):2271-8. PubMed ID: 17693071
[TBL] [Abstract][Full Text] [Related]
8. Shotgun proteomic analysis of human-induced sputum.
Nicholas B; Skipp P; Mould R; Rennard S; Davies DE; O'Connor CD; Djukanović R
Proteomics; 2006 Aug; 6(15):4390-401. PubMed ID: 16819730
[TBL] [Abstract][Full Text] [Related]
9. The proteomic advantage: label-free quantification of proteins expressed in bovine milk during experimentally induced coliform mastitis.
Boehmer JL; DeGrasse JA; McFarland MA; Tall EA; Shefcheck KJ; Ward JL; Bannerman DD
Vet Immunol Immunopathol; 2010 Dec; 138(4):252-66. PubMed ID: 21067814
[TBL] [Abstract][Full Text] [Related]
10. 2-DE and LC-MS/MS for a comparative proteomic analysis of BALf from subjects with different subsets of inflammatory myopathies.
Passadore I; Iadarola P; Di Poto C; Giuliano S; Montecucco C; Cavagna L; Bonino C; Meloni F; Fietta AM; Lisa A; Salvini R; Bardoni AM
J Proteome Res; 2009 May; 8(5):2331-40. PubMed ID: 19301896
[TBL] [Abstract][Full Text] [Related]
11. Global and targeted quantitative proteomics for biomarker discovery.
Veenstra TD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
[TBL] [Abstract][Full Text] [Related]
12. Proteomics of bronchoalveolar lavage fluid.
Wattiez R; Falmagne P
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):169-78. PubMed ID: 15652807
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of bronchoalveolar lavage fluid samples obtained from West Highland White Terriers with idiopathic pulmonary fibrosis, dogs with chronic bronchitis, and healthy dogs.
Lilja-Maula LI; Palviainen MJ; Heikkilä HP; Raekallio MR; Rajamäki MM
Am J Vet Res; 2013 Jan; 74(1):148-54. PubMed ID: 23270360
[TBL] [Abstract][Full Text] [Related]
14. Screening for serological biomarkers of pancreatic cancer by two-dimensional electrophoresis and liquid chromatography-tandem mass spectrometry.
Wang Y; Kuramitsu Y; Yoshino S; Takashima M; Zhang X; Ueno T; Suzuki N; Oka M; Nakamura K
Oncol Rep; 2011 Jul; 26(1):287-92. PubMed ID: 21519797
[TBL] [Abstract][Full Text] [Related]
15. Laboratory markers for COPD in "susceptible" smokers.
Tzortzaki EG; Tsoumakidou M; Makris D; Siafakas NM
Clin Chim Acta; 2006 Feb; 364(1-2):124-38. PubMed ID: 16139829
[TBL] [Abstract][Full Text] [Related]
16. High-resolution mass spectrometry proteomics for the identification of candidate plasma protein biomarkers for chronic obstructive pulmonary disease.
York TP; van den Oord EJ; Langston TB; Edmiston JS; McKinney W; Webb BT; Murrelle EL; Zedler BK; Flora JW
Biomarkers; 2010 Jun; 15(4):367-77. PubMed ID: 20429838
[TBL] [Abstract][Full Text] [Related]
17. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease.
Ohlmeier S; Vuolanto M; Toljamo T; Vuopala K; Salmenkivi K; Myllärniemi M; Kinnula VL
J Proteome Res; 2008 Dec; 7(12):5125-32. PubMed ID: 19367700
[TBL] [Abstract][Full Text] [Related]
18. Clinical proteomics: liquid chromatography-mass spectrometry purification systems.
Henry M; Meleady P
Methods Mol Biol; 2011; 681():473-83. PubMed ID: 20978984
[TBL] [Abstract][Full Text] [Related]
19. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
20. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
Ekegren T; Hanrieder J; Bergquist J
J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
